Page 11 - Galt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Galt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Galt Today - Breaking & Trending Today

HC Wainwright Weighs in on Galectin Therapeutics Inc.'s FY2027 Earnings (NASDAQ:GALT)

Galectin Therapeutics Inc. (NASDAQ:GALT – Get Rating) – Investment analysts at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Galectin Therapeutics in a research note issued on Wednesday, May 17th. HC Wainwright analyst E. Arce now expects that the company will post earnings of $1.45 per share for the year, down from […] ....

Investors Services , Galectin Therapeutics Inc , Atria Wealth Solutions Inc , Financial Services Group Inc , Millennium Management , Galectin Therapeutics , Get Rating , Galectin Therapeutic , Wealth Solutions , Street Corp , Services Group , Galectin Therapeutics Daily , Nasdaq Galt , Earnings Estimates , Hc Wainwright ,

Galectin Therapeutics (NASDAQ:GALT) Stock Price Passes Above 200 Day Moving Average of $1.53

Galectin Therapeutics Inc. (NASDAQ:GALT – Get Rating) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.53 and traded as high as $1.85. Galectin Therapeutics shares last traded at $1.77, with a volume of 31,522 shares. Wall Street Analyst Weigh In GALT has been the […] ....

Investors Services , Galectin Therapeutics Company Profile , Financial Services Group Inc , Millennium Management , Benjaminf Edwards Company Inc , Galectin Therapeutics Inc , Galectin Therapeutics , Get Rating , Therapeutics Trading Down , Services Group , Street Corp , Galectin Therapeutics Daily , Nasdaq Galt ,

Galectin Therapeutics (NASDAQ:GALT) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a research note released on Wednesday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $11.00 price objective on shares of Galectin Therapeutics in a research note on Friday, March 3rd. […] ....

Millennium Management , Galectin Therapeutics Inc , Galectin Therapeutics Company Profile , Commonwealth Equity Services , Virtu Financial , Benjaminf Edwards Company Inc , Galectin Therapeutics , Get Rating , Street Group , Equity Services , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,

Galectin Therapeutics (NASDAQ:GALT) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a report released on Wednesday. The firm set a “hold” rating on the stock. Separately, HC Wainwright reissued a “buy” rating and issued a $11.00 price target on shares of Galectin Therapeutics in a research report on Friday, March 3rd. […] ....

Commonwealth Equity Services , Atria Wealth Solutions Inc , Galectin Therapeutics Company Profile , Financial Services Group Inc , Millennium Management , Galectin Therapeutics Inc , Galectin Therapeutics , Get Rating , Wealth Solutions , Street Corp , Equity Services , Services Group , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,